Streetbeat News

Products Services

BIIB

Biogen is set to present new data at the Clinical Trials on Alzheimer's Disease (CTAD) 2023 meeting on October 27-28. The data could potentially impact the company's standing in the Alzheimer's treatment market.

Portfolio Pulse from Bill Haddad

October 19, 2023 | 11:31 am

BCYC

Bicycle Therapeutics' lead candidate BT8009 for metastatic bladder cancer has been selected for a pilot program launched by the FDA. The program focuses on Chemistry, Manufacturing and Controls development and readiness.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 11:24 am

BMY

HALO

Halozyme Therapeutics has highlighted the positive results of Bristol Myers Squibb's Phase 3 CheckMate-67T trial. The trial used Halozyme's ENHANZE drug delivery technology for the subcutaneous administration of Nivolumab, a treatment for advanced or metastatic clear cell renal cell carcinoma.

Portfolio Pulse from Bill Haddad

October 19, 2023 | 11:19 am

ACXP

Acurx Pharmaceuticals has announced that it will present scientific posters and presentations on its drug, Ibezapolstat, at the ClostPath 2023 and IDWeek 2023 scientific conferences.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 11:12 am

TNXP

Tonix Pharmaceuticals presented preclinical data on its horsepox-based live virus vaccine platform at the World Vaccine Congress Europe. The data demonstrated the attenuation of TNX-801 compared to modern vaccinia vaccines.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 11:10 am

BMY

Bristol Myers Squibb's Phase 3 Checkmate -67T noninferiority trial of subcutaneous Opdivo (Nivolumab) compared to intravenous Opdivo for clear cell renal cell carcinoma met its co-primary pharmacokinetics endpoints, key secondary endpoint.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 11:08 am

STN

Stantec has announced that it is entering the design phase for a $100M potable water supply project in Hillsborough County, Tampa Bay.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 10:57 am

LNN

Lindsay Corporation expects robust sales volume levels in developed international markets in Q1, led by strong demand in Brazil. The company also anticipates increased U.S. infrastructure spending to boost its Road Zipper System leasing and sales of road safety projects.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 10:53 am

BNTX

BioNTech has announced that the first patient has been treated in a Phase 2 trial of mRNA-based individualized neoantigen-specific immunotherapy candidate Autogene Cevumeran (BNT122, RO7198457) in resected pancreatic ductal adenocarcinoma.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 10:49 am

DNMR

Danimer Scientific, BIOLO, and Bolthouse Farms have announced the commercialization of home compostable packaging for fresh vegetables and fruit produce with Meijer Stores. This move is part of their sustainability efforts and could potentially reduce plastic waste.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 10:39 am